- ‘Tis the Season: London florist creates $4.6 million Christmas wreath
- No tailgating allowed at Super Bowl XLVIII
- Pentagon to transport African troops to Central African Republic
- Chinese man fed up with his girlfriend’s shopping jumps to his death
- Ukraine leader to talk with protesters; Washington urges caution
- Pope Francis: A nun saved my life
- Israeli P.M. Netanyahu backs out of Mandela funeral
- Elian Gonzalez makes first trip outside Cuba since custody battle
- U.S., British intelligence agents enter online sci-fi world to spy on gamers
- Sarah Palin to host the outdoors show ‘Amazing America’
FDA exec: agency too slow to order J&J recall
WASHINGTON (AP) - The Food and Drug Administration should have acted sooner to halt a secret recall by Johnson & Johnson in which the company last year bought up defective packets of Motrin from stores across the country, a top official from the agency told members of Congress.
FDA deputy commissioner Dr. Joshua Sharfstein on Thursday disclosed new details about when the agency learned of the so-called phantom recall. The recall is at the center of the investigation by the House Committee on Oversight and Government Reform.
Sharfstein and J&J executives testified at the committee's second hearing into broader quality problems that have forced J&J to recall tens of millions of bottles of popular painkillers and other nonprescription medications in the past year.
Sharfstein said that J&J informed the FDA of its plan to repurchase the defective Motrin _ which did not dissolve correctly _ in April 2009.
"From this point, it took until July for the FDA to tell the company that a recall should be conducted," states Sharfstein's testimony. "In my opinion that message should have been given sooner."
However, Sharfstein stressed that the FDA did not know J&J had instructed contractors to pose as regular customers while buying the product, and not alert store employees to their activity.
"Based on the documents I reviewed, I don't see any indication that the FDA was aware of the surreptitious, lying nature of the recall," he said.
Sharfstein used his testimony to point out the limits of FDA's authority, which do not allow the agency to order recalls. Recalls are initiated by manufacturers, who alert the FDA to their plans. Companies are advised to work with the agency, although this isn't a legal requirement.
Oversight and Government Reform Chairman Edolphus Towns has introduced a bill that would give the agency the power to order recalls.
"Even if the FDA had been notified about the Motrin problem, the agency did not have the legal authority to order a recall," Towns said. "This needs to be rectified."
Earlier Thursday, William Weldon, J&J's chief executive, said his company "let the public down" with a string of recalls stretching back over a year, according prepared testimony. The maker of trusted brands like Tylenol and Benadryl, J&J has announced nine recalls of drugs for children and adults since last September. Problems ranged from too much of active ingredient to tiny shards of metal. This summer, J&J also recalled some hip implants and contact lenses.
Weldon also suggested the company made a serious mistake when it hired a third-party contractor to buy up bottles of defective lots of Motrin, rather than issuing a formal recall.
"This episode was not a model for how I would like to see Johnson & Johnson companies approach problems with defective products," Weldon said.
Weldon missed the committee's hearing in May because of back surgery.
J&J executives say the FDA was aware of the purchasing program, but FDA officials deny that claim.
Lawmakers also will question J&J executive Colleen Goggins, who oversaw the consumer division of the company's McNeil Healthcare unit during the recalls.
At the May hearing, Goggins told lawmakers she had no knowledge of instructions to contractors involved in the phantom recall to not tell store employees what they were doing. In her testimony Thursday, Goggins acknowledged that the company wrote those instructions.
"Based on what I have learned since May, I believe that McNeil should have handled things differently," Goggins said.
Goggins will retire in March, Johnson & Johnson announced this month.
By Tom Fitton
New photos confirm the attack's coordination and its cover-up
- Chinese man fed up with his girlfriend's shopping jumps to his death
- Israeli P.M. Benjamin Netanyahu backs out of Nelson Mandela funeral
- Obama lied about Syrian chemical attack, 'cherry-picked' intelligence: report
- CURL: Obama tells a whopper on IRS scandal
- Lawmakers see 'false narrative' of Obama as a terrorist fighter
- MSNBC host: Obamacare a 'wealthy white men' racist word
- Satanists petition for statue at Oklahoma Statehouse
- Inside China: Nuclear submarines capable of widespread attack on U.S.
- MILLER: Brady Campaign says Colorado recalls due to NRA, not grassroots opposition to gun control
- Ted Cruz sees legal landmines ahead for Obamacare
Independent voices from the The Washington Times Communities
The Constitution: Every issue, every time. No exceptions, no excuses. And how to get from here to there.
Crystal Wright is a black conservative woman living in Washington, D.C.
All of the world’s problems, solved on your back porch
Why can’t humans just be free to be humans?
White House pets gone wild!
Let it snow